About this study

This project will examine how an acute single dose of Methylphenidate (Ritalin® 10mg) affects visual attention, subjective mood assessments and driving performance. Participants can be aged between 21 and 40 years old, in good health and have a current (valid) full driver's licence (no ‘P’ plates).

What’s involved?

Participants will be asked to attend Swinburne University on three separate occasions:

  • one screening session for a maximum of 1.5 hours
  • two testing sessions (one week apart) for three hours each.

In each testing session, participants will receive either Methylphenidate (Ritalin® 10mg) or a placebo only. They will be reimbursed for their time and travel for their participation in the study.

Complete the pre-screening survey

For further enquiries


Our research ethics and integrity

Our researchers are committed to the highest ethical, professional and scholarly standards. All our studies conform to the Australian Code for the Responsible Conduct of Research, Good Clinical Practice and the National Statement on Ethical Conduct in Human Research.

Explore more from our centre

Contact the Centre for Human Psychopharmacology

There are many ways to engage with us. If your organisation is dealing with a complex problem, get in touch to discuss how we can work together to provide solutions. Call us on +61 3 9214 4444 or email chp@swinburne.edu.au

Contact us